4.7 Article

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Related references

Note: Only part of the references are listed.
Editorial Material Multidisciplinary Sciences

Rapid COVID-19 vaccine development

Barney S. Graham

SCIENCE (2020)

Editorial Material Multidisciplinary Sciences

A strategic approach to COVID-19 vaccine R&D

Lawrence Corey et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

News Item Multidisciplinary Sciences

THE RACE FOR CORONAVIRUS VACCINES

Ewen Callaway

NATURE (2020)

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Seth Flaxman et al.

NATURE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Multidisciplinary Sciences

SARS-CoV-2 vaccines in development

Florian Krammer

NATURE (2020)

Letter Medicine, Research & Experimental

SARS-CoV-2 reinfection in two patients who have recovered from COVID-19

Kang Zhang et al.

PRECISION CLINICAL MEDICINE (2020)

Letter Immunology

Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020

Paul K. S. Chan et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Immunology

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

Steven Sanche et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Immunology

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Immunology

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus

Daniel C. Payne et al.

EMERGING INFECTIOUS DISEASES (2016)